Suppr超能文献

[肾移植麻醉:阿曲库铵持续神经肌肉阻滞及硝苯地平处理术中高血压]

[Anesthesia for renal transplantation: continuous neuromuscular blockade with atracurium and the management of intraoperative hypertension with nifedipine].

作者信息

Blobner M, Felber A R, Jelen G, Gögler S, Jelen-Esselborn S

机构信息

Institut für Anästhesiologie am Klinikum rechts der Isar der Technischen Universität München.

出版信息

Anaesthesiol Reanim. 1993;18(4):92-4, 97-9.

PMID:8240642
Abstract

Patients undergoing kidney transplantation often suffer from essential hypertension and coronary artery disease, for which perioperative treatment with nifedipine proved to be effective. If calcium-channel blockers and nondepolarizing muscle relaxants are used simultaneously, their synergistic effect at the neuromuscular cleft must be considered. On the other hand because of its extrarenal elimination no significantly altered effects are expected for patients with terminal renal failure. This prospective study comprised 30 patients undergoing kidney transplantation who were 2 kg over normal weight after a preoperative dialysis and infusion of lactated Ringer solution. Fifteen minutes after introduction of balanced anaesthesia with isoflurane, nitrous oxide and fentanyl, patients were assigned to the treatment group (N) with hypertension (mean arterial pressure (MAP > 110 mmHg) and subsequent management with nifedipine or to the control group (0). Treatment was aimed at keeping MAP between 90 and 110 mmHg. The neuromuscular status was electromyographically assessed by the train-of-four-principle. There were evaluated the duration of action of the initial dose of atracurium (0.5 mg/kg) from injection time to T1 = 2% (WZ 2), the dose of atracurium for a continuous neuromuscular blockade (DD 98 in mg/kg/h), the recovery time and the recovery index. Fourteen patients with hypertension received a bolus of 10 micrograms/kg nifedipine. A significant reduction in blood pressure (p < 0.05) to the desired range was achieved by a subsequent infusion of nifedipine of 5 to 40 micrograms/kg/h. In 16 patients MAP was kept between 90 and 100 mmHg without any additional therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

接受肾移植的患者常患有原发性高血压和冠状动脉疾病,硝苯地平围手术期治疗已证明对这些疾病有效。如果同时使用钙通道阻滞剂和非去极化肌松药,必须考虑它们在神经肌肉接头处的协同作用。另一方面,由于其肾外清除途径,预计终末期肾衰竭患者使用该药时效果不会有显著改变。这项前瞻性研究纳入了30例接受肾移植的患者,这些患者在术前透析并输注乳酸林格液后体重比正常体重超出2kg。在使用异氟烷、氧化亚氮和芬太尼进行平衡麻醉15分钟后,将血压高于正常(平均动脉压(MAP)>110mmHg)的患者分配至治疗组(N),随后用硝苯地平治疗,其余患者分配至对照组(O)。治疗目标是将MAP维持在90至110mmHg之间。通过四个成串刺激原则对神经肌肉状态进行肌电图评估。评估了阿曲库铵初始剂量(0.5mg/kg)从注射到T1=2%(WZ 2)的作用持续时间、维持持续神经肌肉阻滞的阿曲库铵剂量(DD 98,mg/kg/h)、恢复时间和恢复指数。14例高血压患者接受了10μg/kg的硝苯地平推注。随后以5至40μg/kg/h的速度输注硝苯地平,使血压显著降低至理想范围(p<0.05)。16例患者未接受任何额外治疗,MAP维持在90至100mmHg之间。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验